Coordonnées

Maison Médicale Laennec

Rue du Val d'Orient

22690 Pleudihen sur Rance

 

www.cabmedpleudihen.fr

cabmedmg@outlook.fr

Tél : 02 96 83 20 25

----------------------

Publié par Cabinet Médical des Drs PANGAULT et HAMONIC

Levez le doute:Étude d'efficacité du vaccin antigrippal chez des sujets âgés.bandeau__pp.gif


Résultats d'une méta-analyse de 18 cohortes (> 65 ans) incluant 713.872 personnes saisons (10 saisons) d'observation :

contrairement à certains doutes émis sur le bénéfice de la vaccination,

celle-ci a
diminué de 27 % le risque d'hospitalisation pour pneumopathie ou grippe
et de 48 % le risque de décès.



Nichol & Coll., New England Journal of Medicine, 4 octobre 2007 ; 357 : 1373-1381.

ABSTRACT

Background Reliable estimates of the effectiveness of influenza vaccine among persons 65 years of age and older are important for informed vaccination policies and programs. Short-term studies may provide misleading pictures of long-term benefits, and residual confounding may have biased past results. This study examined the effectiveness of influenza vaccine in seniors over the long term while addressing potential bias and residual confounding in the results.

Methods Data were pooled from 18 cohorts of community-dwelling elderly members of one U.S. health maintenance organization (HMO) for 1990–1991 through 1999–2000 and of two other HMOs for 1996–1997 through 1999–2000. Logistic regression was used to estimate the effectiveness of the vaccine for the prevention of hospitalization for pneumonia or influenza and death after adjustment for important covariates. Additional analyses explored for evidence of bias and the potential effect of residual confounding.


Results There were 713,872 person-seasons of observation. Most high-risk medical conditions that were measured were more prevalent among vaccinated than among unvaccinated persons. Vaccination was associated with a 27% reduction in the risk of hospitalization for pneumonia or influenza (adjusted odds ratio, 0.73; 95% confidence interval [CI], 0.68 to 0.77) and a 48% reduction in the risk of death (adjusted odds ratio, 0.52; 95% CI, 0.50 to 0.55). Estimates were generally stable across age and risk subgroups. In the sensitivity analyses, we modeled the effect of a hypothetical unmeasured confounder that would have caused overestimation of vaccine effectiveness in the main analysis; vaccination was still associated with statistically significant — though lower — reductions in the risks of both hospitalization and death.

Conclusions During 10 seasons, influenza vaccination was associated with significant reductions in the risk of hospitalization for pneumonia or influenza and in the risk of death among community-dwelling elderly persons. Vaccine delivery to this high-priority group should be improved.



Pour être informé des derniers articles, inscrivez vous :